- Home
- CFFI vs LXEO Comparison
CFFI vs LXEO Comparison
Compare CFFI & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CFFI
- LXEO
- Stock Information
- Founded
- CFFI 1927
- LXEO 2017
- Country
- CFFI United States
- LXEO United States
- Employees
- CFFI N/A
- LXEO N/A
- Industry
- CFFI Major Banks
- LXEO
- Sector
- CFFI Finance
- LXEO
- Exchange
- CFFI Nasdaq
- LXEO Nasdaq
- Market Cap
- CFFI 248.5M
- LXEO 252.4M
- IPO Year
- CFFI 1998
- LXEO 2023
- Fundamental
- Price
- CFFI $72.50
- LXEO $6.14
- Analyst Decision
- CFFI
- LXEO Strong Buy
- Analyst Count
- CFFI 0
- LXEO 5
- Target Price
- CFFI N/A
- LXEO $23.80
- AVG Volume (30 Days)
- CFFI 12.4K
- LXEO 274.8K
- Earning Date
- CFFI 01-22-2025
- LXEO 12-31-2024
- Dividend Yield
- CFFI 2.41%
- LXEO N/A
- EPS Growth
- CFFI N/A
- LXEO N/A
- EPS
- CFFI 5.66
- LXEO N/A
- Revenue
- CFFI $114,783,000.00
- LXEO N/A
- Revenue This Year
- CFFI N/A
- LXEO N/A
- Revenue Next Year
- CFFI N/A
- LXEO N/A
- P/E Ratio
- CFFI $12.89
- LXEO N/A
- Revenue Growth
- CFFI N/A
- LXEO N/A
- 52 Week Low
- CFFI $33.51
- LXEO $5.77
- 52 Week High
- CFFI $80.87
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- CFFI 44.28
- LXEO 35.77
- Support Level
- CFFI $76.31
- LXEO $6.78
- Resistance Level
- CFFI $80.87
- LXEO $7.40
- Average True Range (ATR)
- CFFI 2.94
- LXEO 0.66
- MACD
- CFFI -1.07
- LXEO -0.13
- Stochastic Oscillator
- CFFI 14.95
- LXEO 1.34
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum revenue from the Community Banking segment.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.